Cancer Research UK logo.
SearchDonate
  • Search

A study of FOLFOX-A chemotherapy for cancer of the pancreas that has spread (PRIMUS 001)

Overview

Cancer types:

Pancreatic cancer

Status:

Closed

Phase:

Phase 2

Details

This study is comparing FOLFOX-A chemotherapy with AG chemotherapy for pancreatic cancer that has spread elsewhere in the body. It is for people who haven’t had treatment for pancreatic cancer that has spread.

The Primus 001 study is part of a large research programme looking at new treatments for cancer of the pancreas. To take part in Primus 001, you must have already joined a study called Precision Panc. In this study, your doctor looked at the make up of your cancer and they have now matched you to have the treatment in this trial.

Cancer Research UK supports this trial.

Recruitment start: 11 January 2018

Recruitment end: 31 December 2024

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Dr Janet Graham

Supported by

Cancer Research UK

NHS Greater Glasgow and Clyde

Celgene

Last reviewed: 2 January 2025

CRUK internal database number: 14714

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.